GENinCode UK Ltd. (GB:GENI) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
GENinCode UK Ltd. presented new findings at the European Society of Cardiology Congress, demonstrating that CARDIO inCode-Score® can predict coronary heart disease (CHD) risk by considering both genetic factors and family history. The study showed a significant increase in CHD risk with a high polygenic risk score and positive family history, emphasizing the need for a comprehensive approach to preventive care. The company’s technology aims to enhance patient risk assessment, facilitating earlier and more effective interventions for those at high genetic risk of CHD.
For further insights into GB:GENI stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue